Skip to main content
Log in

The effect of furazolidone and furaltadone on drug metabolism in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

This work examines the effect of oral treatment of rats with the nitrofuran drugs furazolidone (FZ) and furaltadone (F) at doses of 100, 200 and 400 mg/kg for 4 days, or F in the drinking water at concentrations of 0.1, 0.2 and 0.4% w/v for 14 days, on drug metabolism in vivo. FZ at doses of 200 and 400 mg/kg, and F at a dose of 400 mg/kg or at a concentration of 0.4% w/v in water depressed growth and prolonged pentobarbitone-induced sleeping time. Treatment also significantly increased the blood concentration of metronidazole when measured 30 and 40 min after metronidazole administration. Administration of tremorine (25 mg/kg, i.p.) to control vehicle-treated rats produced within 2–3 min tremors, piloerection, profuse salivation, defecation urination and chromodacryorrhesis (red tears). The onset of appearance of these signs was delayed to 7–12 min in rats pretreated with FZ or F (100 mg/kg, 4 days) or cimetidine (50 mg/kg, i.p.) given 45 min earlier. Taken together, these results suggest that FZ and F inhibit drug metabolism in rats. Treatment with these nitrofuran drugs may alter the disposition of certain drugs which may be given concomitantly with them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Phillips K.F., Haley F.I. (1986): The use of furoxone: a perspective [Review]. J. Intern. Med. Res., 14, 19–29.

    CAS  Google Scholar 

  2. Sethurman S., Mahmoud M., Kareem S. (1994): Furazolidone in multi-resistant childhood typhoid fever. Ann. Trop. Paediatr., 14, 321–324.

    Google Scholar 

  3. Walzer P.D., Kim C.J., Foy J., Zhang J.L. (1991): Furazolidone and nitrofurantoin in the treatment of experimentalPneumocystis carinii pneumonia. Antimicrob. Agents Chemother., 35, 158–163.

    PubMed  CAS  Google Scholar 

  4. Zheng Z.T., Wang Y.B. (1992): Treatment of peptic ulcer disease with furazolidone. J. Gastroenterol. Hepatol., 7, 533–537.

    Article  PubMed  CAS  Google Scholar 

  5. Ali B.H. (1991): Effects of nitrofurans on duodenal ulceration induced by cysteamine or indomethacin. Pharmacology, 42, 49–53.

    Article  PubMed  CAS  Google Scholar 

  6. Ali B.H. (1983): Some pharmacological and toxicological properties of furazolidone. Vet. Res. Commun., 6, 1–11.

    Article  PubMed  CAS  Google Scholar 

  7. Ali B.H. (1989): Pharmacology and toxicity of furazolidone in man and animals: some recent research. Gen. Pharmacol., 20, 557–563.

    PubMed  CAS  Google Scholar 

  8. Czamecki C.M. (1980): Furazolidone-induced cardiomyopathy-biochemical model for the study of cardiac hypertrophy and congestive heart failure. Avian Dis., 24, 120–138.

    Article  Google Scholar 

  9. Ali B.H., Idris O.F., Hamid A. (1988): Some effects of furaltadone in chickens. Proc. 4th EAVPT Congress, Budapest, pp 48–49.

  10. Bartlet A.L., Harvey S., Klandorf H. (1990): Contrasting effects of nitrofurans on plasma corticosterone in chickens following administration as a bolus or diet additive. J. Vet. Pharmacol. Ther., 13, 261–269.

    Article  PubMed  CAS  Google Scholar 

  11. Bartlet A.L., Khan F.H. (1990): Effects of nitrofurans on adrenal cortical tissue in chickens. J. Vet. Pharmacol. Ther., 13, 206–216.

    Article  PubMed  CAS  Google Scholar 

  12. Fukuhara M., Takabatake E. (1977): The effect of nitrofuran derivatives on hepatic microsomal mixed-function oxidase activity in rats. Toxicol. Appl. Pharmacol., 42, 571–581.

    Article  PubMed  CAS  Google Scholar 

  13. Dubin M., Villamil S.H., Blumenfield P., Stoppani A.O. (1991) Inhibition of microsomal lipid peroxidation and cytochrome P-450 catalysed reactions by nitrofuran compounds. Free Rad. Res. Commun., 14, 419–431.

    Article  CAS  Google Scholar 

  14. Ali B.H., Bartlet A.L. (1980): Inhibition of monoamine oxidase by furazolidone in chickens and the influence of alimentary flora thereon. Br. J. Pharmacol., 71, 219–224.

    PubMed  CAS  Google Scholar 

  15. Czeczot H., Szeliga M.K., Bilbin M. (1992): The effect of nitrofurazone and furazolidone on induction of cytochrome-P-450 dependent monooxygenase system. Acta Biochim. Pol., 39, 128–131.

    Google Scholar 

  16. Sasaki N (1994): Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat. J. Vet. Med. Sci., 56, 667–670.

    PubMed  CAS  Google Scholar 

  17. Urtasun R. C., Chapman J.D., Band P. et al. (1975): Phase I study of high dose metronidazole. Radiology, 117, 129–133.

    PubMed  CAS  Google Scholar 

  18. Sharif S.L., Ali B.H. (1994): The effect of grapefruit juice on drug metabolism in rats. Food Chem. Toxicol., 32, 1169–1171.

    Article  PubMed  CAS  Google Scholar 

  19. Loft S. (1990): Metronidazole and antipyrine as probes for the study of foreign compound metabolism. Pharmacol. Toxicol., 66 (suppl), 1–31. 05

    Article  PubMed  CAS  Google Scholar 

  20. Vesell E.S. (1991): The model drug approach in clinical pharmacology. Clin. Pharmacol. Ther., 50, 239–248.

    PubMed  CAS  Google Scholar 

  21. Crossland J. (1980): Lewis Pharmacology, 5th edn. Edinburgh, Churchill Livingstone, p. 595.

    Google Scholar 

  22. Stern V., Hollifield R.D., Wilks S., Buzard J. (1967): Anti-monoamine oxidase action of furazolidone. J. Pharm. Exp. Ther., 156, 492–499.

    CAS  Google Scholar 

  23. Ali B.H. (1983): The anti-diamine oxidase effect of furazolidone in rabbits. Comp. Biochem. Physiol., 74C, 109–110.

    CAS  Google Scholar 

  24. Hoogenbroom L.A., Tomassini O., Oorsrong M.B., Kuizer H.A. (1991): Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone. Food Chem. Toxicol., 29, 185–191.

    Article  Google Scholar 

  25. Kato R., Takanaka A., Shoji H (1969): Inhibition of drug metabolizing enzymes of liver microsomes by hydrazine derivatives in relation to their lipid solubility. Jpn. J. Pharmacol., 19, 315–322.

    Article  PubMed  CAS  Google Scholar 

  26. Boobis A.R. (1990): Species variation is the response of the cytochrome P450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica, 20, 1139–1161.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, B.H., Tanira, M.O.M. & Bashir, A.K. The effect of furazolidone and furaltadone on drug metabolism in rats. European Journal of Drug Metabolism and Pharmacokinetics 21, 327–332 (1996). https://doi.org/10.1007/BF03189734

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189734

Keywords

Navigation